Third Harmonic Bio (THRD) Income Statement (2021 - 2025)
Income Statement report data from Mar 31, 2021 to Mar 31, 2025 for Third Harmonic Bio (THRD).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Expenses | |||||||||||||||||
Research And Development | 11M (+1.04%) | 11M (-7.05%) | 11M (+35.16%) | 8.39M (+34.67%) | 6.23M (+5.24%) | 5.92M (-0.84%) | 5.97M (+11.80%) | 5.34M (-20.77%) | 6.74M (-27.21%) | 9.26M (+94.54%) | 4.76M (+13.88%) | 4.18M (-32.69%) | 6.21M (-42.66%) | 11M (+120.12%) | 4.92M | - | - |
Selling General And Administrative | 8.07M (+36.78%) | 5.90M (+2.97%) | 5.73M (+0.88%) | 5.68M (+12.25%) | 5.06M (+12.69%) | 4.49M (-7.99%) | 4.88M (-9.12%) | 5.37M (+2.29%) | 5.25M (+22.38%) | 4.29M (+12.01%) | 3.83M (+6.39%) | 3.60M (+127.85%) | 1.58M (-36.29%) | 2.48M (+217.95%) | 780K | - | - |
Operating Expenses | 19M (+13.87%) | 16M (-3.69%) | 17M (+21.32%) | 14M (+24.62%) | 11M (+8.45%) | 10M (-4.06%) | 11M (+1.31%) | 11M (-10.68%) | 12M (-11.51%) | 14M (+57.74%) | 8.59M (+10.41%) | 7.78M (-0.13%) | 7.79M (-41.47%) | 13M (+133.51%) | 5.70M | - | - |
Depreciation And Amortization | 10K (-75.00%) | 40K | - | - | 10K (-66.67%) | 30K | - | - | - | - | - | - | - | - | - | - | - |
Operating Income | |||||||||||||||||
Operating Income | -18.72M (+13.87%) | -16.44M (-3.69%) | -17.07M (+21.32%) | -14.07M (+24.62%) | -11.29M (+8.56%) | -10.40M (-4.15%) | -10.85M (+1.31%) | -10.71M (-10.68%) | -11.99M (-11.51%) | -13.55M (+57.74%) | -8.59M (+10.41%) | -7.78M (-0.13%) | -7.79M (-41.47%) | -13.31M (+133.51%) | -5.70M | - | - |
Ebit | -18.72M (+13.87%) | -16.44M (-3.69%) | -17.07M (+21.32%) | -14.07M (+24.62%) | -11.29M (+8.56%) | -10.40M (-4.15%) | -10.85M (+1.31%) | -10.71M (-10.68%) | -11.99M (-11.51%) | -13.55M (+57.74%) | -8.59M (+10.41%) | -7.78M (-0.13%) | -7.79M (+13.56%) | -6.86M (+20.35%) | -5.70M (+35.71%) | -4.20M (+86.67%) | -2.25M |
EBITDA | -18.70M (-18.84%) | -23.04M (+66.96%) | -13.80M (+28.85%) | -10.71M (-5.05%) | -11.28M (-33.76%) | -17.03M (+132.02%) | -7.34M (-2.91%) | -7.56M (-36.89%) | -11.98M (-14.67%) | -14.04M (+71.22%) | -8.20M (+6.77%) | -7.68M (-1.41%) | -7.79M (+50.39%) | -5.18M (-29.81%) | -7.38M (+75.71%) | -4.20M (+86.67%) | -2.25M |
Other Income / Expenses | |||||||||||||||||
Other Non Operating Income | -10.00K (0.00%) | -10.00K | - | - | - | 20K (-33.33%) | 30K | - | - | - | - | - | - | 10K | - | - | - |
Net Income | |||||||||||||||||
Income Before Tax | - | -45.47M | - | - | - | -30.82M | - | - | - | -35.15M | - | - | - | -29.61M | - | - | - |
Net Income From Continuing Operations | -15.83M (+20.75%) | -13.11M (-5.00%) | -13.80M (+28.85%) | -10.71M (+36.26%) | -7.86M (+14.91%) | -6.84M (-6.81%) | -7.34M (-2.91%) | -7.56M (-16.83%) | -9.09M (-20.89%) | -11.49M (+40.12%) | -8.20M (+6.77%) | -7.68M (-1.29%) | -7.78M (-50.70%) | -15.78M (+113.82%) | -7.38M (+75.71%) | -4.20M (+86.67%) | -2.25M |
Net Income | -15.83M (+20.75%) | -13.11M (-5.00%) | -13.80M (+28.85%) | -10.71M (+36.26%) | -7.86M (+14.91%) | -6.84M (-6.81%) | -7.34M (-2.91%) | -7.56M (-16.83%) | -9.09M (-20.89%) | -11.49M (+40.12%) | -8.20M (+6.77%) | -7.68M (-1.29%) | -7.78M (-50.70%) | -15.78M (+113.82%) | -7.38M (+75.71%) | -4.20M (+86.67%) | -2.25M |